Product Safety Recalls

Product Recall Tracker

POSACONAZOLE Recall D-0268-2023

Description: Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.

POSACONAZOLE Recall D-0268-2023 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0268-2023
Event ID91577
BrandPOSACONAZOLE
Generic NamePOSACONAZOLE
ManufacturerPOSACONAZOLE
Original Package?1
Active SubstancePOSACONAZOLE
Drug RouteORAL
DistributionNationwide in the USA
Quantity3665 bottles
Recall ReasonFailed Impurities/Degradation Specifications: High Out Of Specification degradation results.
Drug ClassificationClass II
Drug Code Info20230215
Product NDC70377-038
Product NUIN0000175487 M0002083
Pharma Class (EPC)Azole Antifungal [EPC]
Pharma Class (CS)Azoles [CS]
Recall Initiation Date20230131
Report Date20230215
Classification Date20230214
Address485 HWY 1 (S)
ISELIN, NJ 08830
United States
Recalling FirmBIOCON PHARMA INC
Initial Notification E-Mail
Unique Ingredient Identifier6TK1G07BHZ
Drug Application NumberANDA214476
Structured Product Labeling (SPL ID)b7a2fd29-83b5-6ae6-775c-98f91a6c0ea4
Structured Product Labeling (SPL Set ID)e0e8023a-3c82-e455-a57b-ccc0206ad156
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.